|
|
|
|
| LEADER |
01229nam a2200265 u 4500 |
| 001 |
EB002010655 |
| 003 |
EBX01000000000000001173554 |
| 005 |
00000000000000.0 |
| 007 |
tu||||||||||||||||||||| |
| 008 |
220201 r ||| eng |
| 100 |
1 |
|
|a Tran, Khai
|
| 245 |
0 |
0 |
|a Programs for the reduction or discontinuation of opioids or opioid substitution therapy
|h Elektronische Ressource
|b a review of the clinical effectiveness
|c Khai Tran, Charlene Argáez
|
| 246 |
3 |
1 |
|a Opioid addiction programs
|
| 250 |
|
|
|a Version 1.0
|
| 260 |
|
|
|a Ottawa
|b CADTH
|c 2018, September 7, 2018
|
| 300 |
|
|
|a 1 PDF file (81 pages)
|b illustrations
|
| 505 |
0 |
|
|a Includes bibliographical references
|
| 700 |
1 |
|
|a Argáez, Charlene
|e [author]
|
| 710 |
2 |
|
|a Canadian Agency for Drugs and Technologies in Health
|
| 041 |
0 |
7 |
|a eng
|2 ISO 639-2
|
| 989 |
|
|
|b NCBI
|a National Center for Biotechnology Information
|
| 490 |
0 |
|
|a CADTH rapid response report: summary with critical appraisal
|
| 856 |
4 |
0 |
|u https://www.ncbi.nlm.nih.gov/books/NBK537953
|3 Volltext
|
| 082 |
0 |
|
|a 610
|
| 520 |
|
|
|a The aim of this report is to review the clinical effectiveness and safety of different opioid addiction programs for the management and treatment of opioid use disorder
|